212 related articles for article (PubMed ID: 12122107)
1. The TSH receptor reveals itself.
Davies T; Marians R; Latif R
J Clin Invest; 2002 Jul; 110(2):161-4. PubMed ID: 12122107
[No Abstract] [Full Text] [Related]
2. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
3. Expression of a human thyrotrophin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves' disease.
Huang GC; Collison KS; McGregor AM; Banga JP
J Mol Endocrinol; 1992 Apr; 8(2):137-44. PubMed ID: 1515018
[TBL] [Abstract][Full Text] [Related]
4. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.
Libert F; Lefort A; Gerard C; Parmentier M; Perret J; Ludgate M; Dumont JE; Vassart G
Biochem Biophys Res Commun; 1989 Dec; 165(3):1250-5. PubMed ID: 2610690
[TBL] [Abstract][Full Text] [Related]
5. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
6. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
[No Abstract] [Full Text] [Related]
7. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
8. Recombinant TSH-receptor for determination of TSH-receptor-antibodies.
Ludgate M; Costagliola S; Danguy D; Perret J; Vassart G
Exp Clin Endocrinol; 1992; 100(1-2):73-4. PubMed ID: 1361451
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Brokken LJ; Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
[TBL] [Abstract][Full Text] [Related]
10. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
Gupta MK
Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
[TBL] [Abstract][Full Text] [Related]
12. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30.
Nagayama Y; Rapoport B
J Clin Endocrinol Metab; 1992 Dec; 75(6):1425-30. PubMed ID: 1361193
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
[TBL] [Abstract][Full Text] [Related]
14. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
15. Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction.
Nagayama Y; Rapoport B
Endocrinology; 1992 Aug; 131(2):548-52. PubMed ID: 1322272
[TBL] [Abstract][Full Text] [Related]
16. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
17. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
[TBL] [Abstract][Full Text] [Related]
18. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of the TSH receptor.
Rees Smith B; Furmaniak J
Horm Metab Res Suppl; 1990; 23():28-32. PubMed ID: 2210629
[No Abstract] [Full Text] [Related]
20. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.
Chen CR; Pichurin P; Nagayama Y; Latrofa F; Rapoport B; McLachlan SM
J Clin Invest; 2003 Jun; 111(12):1897-904. PubMed ID: 12813025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
